The slowing of Massachusetts biotech and medical device companies’ stock market launches has left most venture creation firms without exit opportunities, except for one.

Boston Biz Journal https://www.bizjournals.com/boston/news/2019/05/08/in-slow-year-for-life-science-ipos-this-venture.html?ana=RSS&s=article_search